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a b s t r a c t
Although effective liquid chromatography (LC)/mass spectrometry (MS) methods enabling the separa-
tion of phospholipidmolecular species have been developed, there are still problemswith an intracellu-
lar signalingmolecule, phosphatidic acid (PA). In this study, we optimized LC/MS conditions to improve
the quantitative detection of PA molecular species from a cellular lipid mixture. Using the newly de-
veloped LC/MS method, we showed that stimulation of CTLL-2 murine T-lymphocytes by interleukin-2
(IL-2) induced a signiﬁcant increase of 36:1-, 36:2-, 40:5- and 40:6-diacyl-PA. A diacylglycerol kinase
(DGK) inhibitor, R59949, attenuated the increase of 36:1-, 40:5-, 40:6-diacyl-PA, suggesting that DGK
IL-2-dependently and selectively generated these diacyl-PA species.
c© 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Phosphatidic acid (PA) is an important intermediate in the syn-
thesis of all phospholipids and an intracellular signaling molecule
in mammalian cells. PA as a lipid second messenger performs spe-
ciﬁc tasks in a wide range of biological processes [1–3]. For, ex-
ample, PA regulates phosphatidylinositol-4-phosphate-5-kinase, Ras
GTPase-activating protein, Raf-1 kinase and atypical protein kinase
C [3–5]. Therefore, it is essential that the cellular concentrations of
PA are strictly regulated by the action of metabolic enzymes. PA as
an intracellular signaling lipid is generated by phosphorylation of di-
acylglycerol by diacylglycerol kinase (DGK) [5–9] and hydrolysis of
phosphatidylcholine by phospholipase D (PLD) [2–4].
To date, 10 mammalian DGK isozymes (α, β, γ, δ, η, κ, ε, ζ, ι
and θ) have been identiﬁed, and these isozymes are subdivided into
ﬁve groups according to their structural features [5–9]. Recent studies
have revealed that the DGK isozymes are crucial for a wide variety
of signal transduction pathways involved in development, neural and
immune responses, cytoskeleton reorganization, glucose incorpora-
tion and carcinogenesis [5–10]. For example, the α-isozyme of DGKAbbreviations: DGK, diacylglycerol kinase; DMEM, Dulbecco’s modiﬁed Eagle’s
medium; ESI, electrospray ionization; FBS, fetal bovine serum; IL-2, interleukin-2; LC,
liquid chromatography;MEF,mouse embryonic ﬁbroblast;MS,mass spectrometry; PA,
phosphatidic acid; PLD, phospholipase D.
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cinoma [12]. Moreover, PA produced by DGKα, which is abundantly
expressed in T-lymphocytes and the thymus [13,14], is necessary for
the interleukin-2 (IL-2)-induced G1-to-S transition of T-lymphocytes
[15,16]. Furthermore, Jones et al. revealed that IL-2 causes an increase
of PA in CTLL-2 murine T-lymphocytes that lack the IL-2-stimulating
PLD activity [17,18]. These studies indicate that the DGK-dependent
accumulation of PA is important for IL-2-induced T-cell proliferation.
However, it remains unclear what PA molecular species are involved
during IL-2-dependent T-cell proliferation.
To detect molecular species of phospholipids in cells, liquid
chromatography/electrospray ionizationmass spectrometry (LC/ESI-
MS) is a powerful tool [19,20]. However, there are still problems with
detecting PA. Because PA is aminor component of phospholipids, and
because PA contains a variety of fatty acids, extensively broad PA
peaks inevitably overlap with other major phospholipid peaks, caus-
ing inferior detection, quantiﬁcation and reproducibility. Because of
thesemethodology limitations, the behavior of different PAmolecular
species during cell stimulation is poorly understood.
In this study, we optimized LC conditions to quantitatively and re-
producibly detect PA molecular species using LC/ESI-MS. To test the
developed LC/ESI-MS method, we examined phospholipid mixtures
from various mammalian cells including CTLL-2 T-lymphocytes, and
conﬁrmed that PA species from m/z 591.41 (28:0-PA) to m/z 759.59
(40:0-PA) were quantitatively and reproducibly detected. As a result,
the PA diacyl and alkyl–acyl species proﬁles were found to vary be-
tween different mammalian cell lines. Moreover, we found that IL-2
stimulation caused a DGK-dependent increase of limited molecular
species of PA in CTLL-2 cells..V. Open access under CC BY-NC-ND license.
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Fig. 1. Separation of PA and identiﬁcation of PA molecular species by LC/ESI-MS. (A)
PAs in MEFs were separated from other phospholipids by the Accela LC System using
a UK-Silica column with mobile phases containing 0.28% ammonia. (B) Negative-ion
ESI/MS spectra with PA species from m/z 591.41 (28:0-PA) to m/z 759.59 (40:0-PA)
were identiﬁed. Abbreviations:I.S., internal standard, PA, phosphatidic acid; PC, phos-
phatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phos-
phatidylinositol; PS, phosphatidylserine; SM, sphingomyelin.268 Satoru Mizuno et al. / FEBS
2. Materials and methods
2.1. Cell culture
COS-7 (a simian virus 40-transformed simian kidney cell line),
C2C12 (a mouse myoblast cell line) and HeLa (a human epithelial
carcinoma cell line) cells as well as mouse embryonic ﬁbroblasts
(MEFs), obtained from fetal C57/BL6 mice, were maintained on 100-
mm dishes in Dulbecco’s modiﬁed Eagle’s medium (DMEM, Wako
PureChemicals, Tokyo, Japan) containing10% fetal bovine serum(FBS)
at 37 ◦C in an atmosphere with 5% CO2. CTLL-2 (an IL-2-dependent
mouse cytotoxic T-cell line) and Jurkat (a human T cell lymphoblast-
like cell line) cells were maintained in 75-cm2 ﬂasks in RPMI-1640
medium (Wako Pure Chemicals) containing 10% FBS, 2 mM sodium
pyruvate and 50μM 2-mercaptoethanol. For CTLL-2 cell culture, 100
U/ml IL-2 (human recombinant, Wako Pure Chemicals) was added to
the medium.
2.2. IL-2 stimulation
CTLL-2 cells (grown to 80% conﬂuence) were washed twice with
RPMI-1640. To starve the cells, the washed cell were incubated in
serum- and IL-2-free RPMI-1640 for 90 min. The starved cells were
pre-incubated with or without 25 μM DGK inhibitor R59949 (Merk
Biosciences-Calbiochem, Tokyo, Japan) for 30 min and stimulated
with 200 U/ml IL-2 (Wako Pure Chemicals) for 15 min.
2.3. Lipid extraction and measurement of the phospholipid amount
Cells (grown to 80% conﬂuence) were harvested in phosphate-
buffered saline. Total lipids were extracted from the cells according
to themethod of Bligh andDyer [21]. An aliquot of the extracted lipids
was used for measurement of the amount of inorganic phosphate in
the phospholipid preparation as previously described [22].
2.4. Liquid chromatography
The extracted cellular lipids (5μl) containing 40 pmol of the 28:0-
PA internal standard (Sigma–Aldrich, Tokyo, Japan), were separated
on the LC system (Accela LC Systems, Thermo Fisher Scientiﬁc, Tokyo,
Japan) using a UK-Silica column (3 μm, 150 × 2.0 mm i.d., Imtakt,
Kyoto, Japan). Mobile phase A consisted of chloroform/methanol/
ammonia (89:10:1), and mobile phase B consisted of chloroform/
methanol/ammonia/water (55:39:1:5). Thegradient elutionprogram
was as follows: 30% B for 5 min, 30–60% B over 25 min, 60–70% over
5 min, followed by 70% B for 10 min. The ﬂow rate was 0.3 ml/min,
and the chromatography was performed at 25 ◦C.
2.5. Mass spectrometry
The LC system described above was coupled online to an Exactive
Orbitrap MS (Thermo Fisher Scientiﬁc) equipped with an ESI source.
The ion spray voltage was set to –5 and 5 kV in the negative and posi-
tive ion mode, respectively. The capillary temperature was set to 300
◦C. The other parameters were set according to the manufacturer’s
recommendations. This MS system was controlled by the Xcalibur
software. Individual phospholipids were measured by scanning from
m/z 450 to 1100 in the negative or positive ion modes using an Orbi-
trap Fourier TransformMS with a resolution of 50,000. The MS peaks
were identiﬁed based on their mass/charge (m/z) ratio andwere pre-
sented in the form of X:Y, where X is the total number of carbon atoms
and Y is the total number of double bonds in both acyl chains of the
phospholipid.2.6. Statistics
All LC/ESI-MS data were normalized based on the inorganic phos-
phate content and the intensity of the internal standard and were
represented as the mean ± SD. Statistical analysis was performed by
the two-tailed t-test.
3. Results
3.1. Improvement of PA species detection using LC/ESI-MS
Pettitt et al. and Shui et al. reported that PA molecular species
can be separated from total lipid extracts of eukaryotic cells us-
ing silica column LC/MS [23,24]. We attempted to separate PA
species from total lipids extracted from MEFs according to the previ-
ously reported LC conditions. However, because PA elutes relatively
close to phosphatidylcholine and sphingomyelin using these con-
ditions, PA often overlapped with the major phospholipids (Suppl.
Fig. 1), causing inferior reproducibility. Thus, we optimized the LC
conditions to establish an improved PA separation. We found that
the PA peaks were completely separated from other phospholipid
species when mobile phases A and B were changed to chloroform/
methanol/ammonia (89:10:1) and chloroform/methanol/ammonia/
water (55:39:1:5), respectively (Fig. 1A).
The detected diacyl- and alkyl–acyl-PA species were listed in Ta-
bles 1 and 2 and all had mass accuracies less than ±6 ppm. In ad-
dition, the representative MS spectra pattern of the PA species from
m/z 591.41 (28:0-PA, internal standard) tom/z 759.59 (40:0-PA) was
shown in Fig. 1B. Moreover, we tested the reproducibility of quanti-
tative detection of cellular diacyl-PA species in MEFs. The repeated
Satoru Mizuno et al. / FEBS Open Bio 2 (2012) 267–272 269
Table 1
Identiﬁcation of diacyl-PA species in MEFs.
Species Theoreticalm/z Measuredm/z Mass errora (ppm)
28:0 (I.S.b) 591.4022 591.4052 5.0
30:2 615.4022 615.4049 4.3
30:1 617.4179 617.4209 4.9
30:0 619.4335 619.4364 4.6
32:3 641.4179 641.4195 2.5
32:2 643.4335 643.4371 5.6
32:1 645.4492 645.4524 5.0
32:0 647.4648 647.4674 4.0
34:4 667.4335 667.4352 2.5
34:3 669.4492 669.4516 3.6
34:2 671.4648 671.4683 5.2
34:1 673.4804 673.4831 3.9
34:0 675.4961 675.4965 0.6
36:5 693.4492 693.4517 3.7
36:4 695.4648 695.4673 3.6
36:3 697.4804 697.4836 4.5
36:2 699.4961 699.4991 4.3
36:1 701.5117 701.5138 3.0
36:0 703.5274 703.5265 −1.2
38:7 717.4492 717.4523 4.4
38:6 719.4648 719.4682 4.7
38:5 721.4804 721.4836 4.4
38:4 723.4961 723.4992 4.3
38:3 725.5117 725.5139 3.0
38:2 727.5274 727.5301 3.8
38:1 729.5430 729.5461 4.2
38:0 731.5586 731.5615 3.9
40:6 747.4961 747.4994 4.4
40:5 749.5117 749.5144 3.6
40:4 751.5274 751.5254 −2.6
40:1 757.5743 757.5773 4.0
40:0 759.5899 759.5927 3.7
a Difference between theoreticalm/z and measuredm/z.
b I.S., internal standard.
Table 2
Identiﬁcation of alkyl – acyl-PA species in MEFs.
Species Theoreticalm/z Measuredm/z Mass errora (ppm)
30:1 603.4386 603.4417 5.1
30:0 605.4543 605.4575 5.4
32:3 627.4386 627.4399 2.1
32:1 631.4699 631.4734 5.6
32:0 633.4855 633.4890 5.5
34:4 653.4543 653.4558 2.4
34:3 655.4699 655.4721 3.4
34:2 657.4855 657.4890 5.3
34:1 659.5012 659.5046 5.2
34:0 661.5168 661.5198 4.5
36:6 677.4543 677.4571 4.2
36:5 679.4699 679.4730 4.6
36:4 681.4855 681.4885 4.4
36:3 683.5012 683.5050 5.6
36:2 685.5168 685.5203 5.1
36:1 687.5325 687.5360 5.2
36:0 689.5481 689.5508 3.9
38:7 703.4699 703.4731 4.6
38:6 705.4855 705.4892 5.2
38:5 707.5012 707.5050 5.4
38:1 715.5637 715.5643 0.8
40:2 741.5794 741.5824 4.1
40:1 743.5950 743.5985 4.7
40:0 745.6107 745.6142 4.8
a Difference between theoreticalm/z and measuredm/z.
experiments between periods on a given study day (within-day re-
producibility) and between the three study days (between-day repro-
ducibility) exhibited excellent reproducibility (Suppl. Fig. 2). These
results indicate that our LC/ESI-MS method provided reproducible
and quantitative detection of cellular PA species proﬁles.
To determine recovery rate, a mixture of standard 28:0-, 36:2-,
Fig. 2. Standard curves obtained with the LC/ESI-MS method and PA standards (28:0-
and 38:4-PA). The main panel shows the high-range standard curve (9.50–146 pmol; y
= 4.14 × 106x –29.74 × 106, r = 0.995) and the inset exhibits the low-range standard
curve (0.59–9.50 pmol; y = 1.90 × 106x –1.05 × 106, r = 0.985).
38:4-PA (80 pmol of each) were added to MEFs before and after the
extraction process. The calculated recovery rates were 74.4 ± 10.1%
for a mixture of 28:0-, 36:2 and 38:4-PA. Moreover, we established
standard curves using different amounts (0.59–146 pmol) of stan-
dard 28:0-PA and 38:4-PA. Both 28:0- and 38:4-PA displayed linear
curves in the high and low amount range tested and the slopes of
the linear curves of 28:0-PA and 38:4-PA were very similar (Fig. 2).
In addition, standard curves using various amount of both 28:0- and
38:4-PA showed good linearity at the high (9.50–146 pmol, r> 0.995)
and low ranges (0.59–9.50, r > 0.985), suggesting that the length of
fatty acyl chains and double bond did not affect ionization efﬁciency
signiﬁcantly.
3.2. MS proﬁles of PA species in various mammalian cells
To test the new LC/ESI-MS method, we detected and quanti-
tated PA molecular species in various mammalian cells. The primary
common components in adherent cells (COS7, C2C12 and HeLa cells
(Suppl. Fig. 3) and MEFs (Fig. 3A)) were diacyl-PA species with sat-
urated and mono- and/or di-unsaturated fatty acids (32:1-, 34:1-,
34:2-, 36:1- and 36:2-PA). In addition, several PA species varied in
abundance in the different cell lines: 30:0- and 32:0-PA, which con-
tain only saturated fatty acids, were abundant in MEFs; 40:5-PA in
COS7 cells; 40:6-PA in C2C12 cells; 38:4- and 40:3-PA in HeLa cells.
For non-adherent T cell-derived cell lines (i.e., CTLL-2 and Jurkat),
32:0-, 34:1-, 36:1-, 36:2-, 40:5- and 40:6-PA were abundant in CTLL-
2 cells (Fig. 3C). Compared with the adherent cell lines, 40:5- and
40:6-PA, containing poly-unsaturated fatty acids, were particularly
enriched in the T-cells. Interestingly, PAs in Jurkat cells mainly con-
sisted of 34:0-, 34:1-, 34:2-, 36:1-, 36:2- and 36:3-PA, comprising
>95% of the total PAs (Fig. 3E). These results indicated that the PA
species differed moderately in the different adherent cell lines and
the CTLL-2 cells. Interestingly, the Jurkat cells had a unique PA species
proﬁle.
We next identiﬁed alkyl–acyl-PA species in CTLL-2 cells. The total
amount of alkyl–acyl-PA species was 12.5 ± 0.4% of the total amount
of diacyl-PA species. As shown in Fig. 3D, 32:0-, 34:1-, 34:0- and 38:5-
alkyl–acyl-PA were the major components. The results indicated that
the major alkyl–acyl-PA species differed from the major diacyl-PA
species (Fig. 3C and D). Because alkyl–acyl-PAs in Jurkat cells were
only present in a trace amount (0.2 ± 0.1% of total diacyl-PA), we
could not quantitatively detect those lipids. Alkyl–acyl-PA species in
MEFs (8.6 ± 0.4% of total diacyl-PA), C2C12 cells (3.0 ± 0.1% of total
diacyl-PA) and HeLa cells (16.2 ± 0.1% of total diacyl-PA) exhibited
essential the same proﬁles as those of CTLL-2 cells (Fig. 3 and Suppl.
270 Satoru Mizuno et al. / FEBS Open Bio 2 (2012) 267–272
Fig. 3. Proﬁles of PA species in mammalian cells (MEFs, and CTLL-2 cells and Jurkat
cells). (A, C and E) Themolecular species composition of diacyl-PAs inMEFs (A), CTLL-2
cells (C) and Jurkat cells (E). (B and D) Themolecular species composition of alkyl–acyl-
PAs in MEFs (B) and CTLL-2 cells (D). The values are presented as the mean ± SD (n =
3). N.D., not detected.
Fig. 3). Intriguingly, 38:7-, 36:6-, 38:2-, 40:4- and 40:3-alkyl–acyl-
PA species were enriched in COS7 cells (Suppl. Fig. 3). In summary,
we concluded that the diacyl and alkyl–acyl-PA proﬁles are quite
different among differentmammalian cell lines, and that our new LC/
ESI-MS method reproducibly and quantitatively detected cellular PA
species proﬁles.
3.3. Alteration of PA species levels in CTLL-2 cells by IL-2 stimulation
IL-2 causes an increase in PA [18]. Hence, we analyzed the induc-
tion of PA species by IL-2 stimulation in CTLL-2 cells using our new
LC/ESI-MS method. As shown in Fig. 4A, IL-2 stimulation for 15 min
broadly increased diacyl-PA-species, in particular, 36:2-, 36:1-, 40:5-
and 40:6-diacyl-PAwith statistical signiﬁcance. Interestingly, IL-2 did
not augment the amount of 38:4-PA (1-stearoyl-2-arachidonoyl-PA),
which is generated fromphosphatidylinositol turnover-derived 38:4-
diacylglycerol. In addition, the stimulation also failed to alter the
amounts of 34:0-, 40:4-, 40:3- and 40:2-PA.Wewere unable to detect
any signiﬁcant change in alkyl–acyl-PA species (<10% change) (Fig.
4B).
DGK is activated by IL-2 stimulation and is involved in IL-2-
dependent T-cell proliferation [15,16]. We therefore investigated
whether the statistically signiﬁcant, IL-2-induced increases of 36:2,
36:1-, 40:5- and 40:6-PA were inhibited by a DGK inhibitor, R59949.
R59949 attenuated the IL-2-dependent increases of 36:1-, 40:5- and
Fig. 4. Effects of IL-2 and the DGK inhibitor, R59949, on the PA species level in CTLL-
2 cells. (A and B) The amount of diacyl-PA species (A) and alkyl–acyl-PA species (B)
in IL-2-stimulated or IL-2-unstimulated CTLL-2 cells were measured. The results are
presented as the percentage of the value of PA species in control cells without IL-2
treatment. PA species with >1% of the total diacyl-PA species or alkyl–acyl-PA species
content are shown (Fig. 2C and D). The values are presented as the mean ± SD (n =
5). (C) The amount of diacyl-PA species in IL-2-stimulated or IL-2-unstimulated CTLL2
cells with or without R59949 treatment was measured. The results are presented as
the percentage of the value of PA species in control cells without IL-2 stimulation or
R59949 treatment. The values are presented as the mean ± SD (n = 3). * p < 0.05; ***
p < 0.005.
40:6-PA in CTLL-2 cells, whereas the inhibitor did not affect the in-
crease of 36:2-PA (Fig. 4C). These results strongly suggested that
R59949-sensitive DGK in CTLL-2 cells selectively generated 36:1-
, 40:5- and 40:6-PA in an IL-2-dependent manner. Moreover, the
increases of 30:0-, 32:1-, 36:5-, 36:4- and 36:3-diacyl-PA as well
as 30:0-, 32:1- and 32:2-alkyl–acyl-PA were inhibited by R59949,
whereas those of 34:2, 36:3, 38:6 and 38:5 were not inhibited (data
not shown). Therefore, these R59949-inhibited PA species are likely
generated by the R59949-sensitive DGK.
4. Discussion
Because PA eluted relatively close to phosphatidylcholine and/
or sphingomyelin using previously established methods [23,24], PA
often overlapped with these major phospholipids, causing inferior
reproducibility. For this study, we thus optimized the LC conditions,
including the mobile phase composition and the solvent program to
establish a new LC/ESI-MS system suitable for analysis of PA molec-
ular species (Fig. 1). The LC/ESI-MS system stably and reproducibly
detected PA species from various mammalian cell lines (Figs. 2 and
3 and Suppl. Fig. 3). Using the developed method, we obtained the
following information.
PAs in variousmammalian cell lines (MEFs and COS7, C2C12, HeLa,
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CTLL-2 and Jurkat cells) contained different diacyl and alkyl–acyl
species proﬁles (Fig. 3). In particular, Jurkat T-cells contained quite
different PA proﬁles compared with other cell lines. Diacyl-PAs in
Jurkat cells mainly consisted of 34:0-, 34:1-, 34:2-, 36:1-, 36:2- and
36:3-PA, comprising>95% of the total diacyl-PAs (Fig. 3E). The reason
for the different proﬁles is unknown. Jeong et al. reported that cancer
cells and normal cells have different proﬁles of PAs and individual
phospholipids [25]. PA metabolismmay therefore be abnormal in Ju-
rkat T-cell lymphoma cells. However, because HeLa cells are also de-
rived from cancer cells (human epithelial carcinoma), the difference
in the PA species proﬁle may depend on the nature of the cancer.
Although IL-2 causes an increase in PA in CTLL-2 cells, themolecu-
lar species of PA have not yet been elucidated. In this study, we found
for the ﬁrst time that IL-2 stimulation enhanced the production of
a broad range of diacyl-PA species, in particular 36:2-, 36:1-, 40:5-
and 40:6-diacyl-PAwith statistical signiﬁcance (Fig. 4A). Notably, IL-2
did not increase an amount of 38:4-PA (1-stearoyl-2-arachidonoyl-
PA) produced from phosphatidylinositol turnover-derived 38:4-
diacylglycerol. The results indicate that the IL-2-dependent PA gener-
ation occurs in a phosphatidylinositol turnover-independent fashion.
Therefore, the substrate diacylglycerol is likely supplied from an un-
known source rather than from phosphatidylinositol turnover.
Jones et al. reported that IL-2 mainly stimulates the formation of
alkyl–acyl-PAs, but not diacyl-PAs [18]. However, we detectedmainly
an increase in the diacyl-PA species level. The cause of this discrep-
ancy is unknown at present but may be due to the difference in the
employed methods, e.g., MS analysis by gas chromatography/MS in
Ref. [18] and LC/ESI-MS in the present study.
Of the IL-2-sensitive diacyl-PA species (36:2-, 36:1-, 40:5- and
40:6-diacyl-PA) that showed a statistically signiﬁcant increase (Fig.
4A), only the increase of 36:1-, 40:5- and 40:6-PA was attenuated by
the DGK inhibitor, R59949 (Fig. 4C), indicating that these PA species
were produced by the IL-2-activated, R59949-sensitive DGK. More-
over, 30:0-, 32:1-, 36:5-, 36:4- and 36:3-diacyl-PA as well as 30:0-,
32:1- and 32:2-alkyl–acyl-PA were also sensitive to R59949 and may
thus be products of DGK. R59949 was reported to inhibit calcium-
dependent, type I DGK isozymes (α, β and γ) in vitro [26]. We also
observed that, of the 10 DGK isozymes, this inhibitor strongly in-
hibited DGKα and γ in vitro (Sato and Sakane, unpublished work).
Moreover, we conﬁrmed that DGKα but not DGKβ or γ was highly
expressed in CTLL-2 cells (data not shown). DGKα is activated in re-
sponse to IL-2 stimulation in CTLL-2 cells [17]. However, this cell line
lacks IL-2-induced PLD activity [17]. Hence, DGKα is likely mainly
responsible for the IL-2-dependent production of PA species. More-
over, it is possible that the R59949-insensitive increase of 36:2-PA is
catalyzed by R59949-insensitive DGK or other enzyme(s), including
a trace amount of IL-2-responsive PLD. A conclusive determination
of the IL-2-responsible DGK isozyme(s) was not the purpose of this
study. We are currently characterizing DGK isozymes by performing
several experiments, including DGK isozyme-speciﬁc knockdowns,
and would like to report our results elsewhere in a future work.
In addition to PLD [2–4], DGK appears to participate in various
pathophysiological events by modulating PA levels [5–10]. However,
the cellular behavior of PA species, in particular the inﬂuence of re-
ceptor stimulation on the PA level, has not been clariﬁed, mainly
because of methodological limitations. We developed a new LC/ESI-
MS method using a silica column LC and mobile phases containing
high concentrations of ammonia. Themethod developed in this study
will be advantageous for pathophysiological and lipidomics studies
of cellular responses.
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